BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10527293)

  • 21. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modern diagnosis of gastroesophageal reflux disease (GERD).
    Galmiche JP; Scarpignato C
    Hepatogastroenterology; 1998; 45(23):1308-15. PubMed ID: 9840059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole.
    Kiljander TO; Salomaa ER; Hietanen EK; Terho EO
    Chest; 1999 Nov; 116(5):1257-64. PubMed ID: 10559084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting.
    des Varannes SB; Sacher-Huvelin S; Vavasseur F; Masliah C; Le Rhun M; Aygalenq P; Bonnot-Marlier S; Lequeux Y; Galmiche JP
    World J Gastroenterol; 2006 Apr; 12(16):2569-73. PubMed ID: 16688803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
    Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Composite score of reflux symptoms in diagnosis of gastroesophageal reflux disease.
    Wang JH; Luo JY; Dong L; Gong J; Zuo AL
    World J Gastroenterol; 2004 Nov; 10(22):3332-5. PubMed ID: 15484311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
    Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
    Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supraesophageal manifestations of gastroesophageal reflux disease.
    Al-Sabbagh G; Wo JM
    Semin Gastrointest Dis; 1999 Jul; 10(3):113-9. PubMed ID: 10435698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic cough, asthma, and gastroesophageal reflux.
    Lazenby JP; Harding SM
    Curr Gastroenterol Rep; 2000 Jun; 2(3):217-23. PubMed ID: 10957933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
    Hall J; Dodd S; Durkin M; Sloan S
    Manag Care; 2002 Jul; 11(7 Suppl):14-8. PubMed ID: 12181872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.
    Carlsson R; Dent J; Bolling-Sternevald E; Johnsson F; Junghard O; Lauritsen K; Riley S; Lundell L
    Scand J Gastroenterol; 1998 Oct; 33(10):1023-9. PubMed ID: 9829354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI; Haslam RR; Lundborg P; Davidson GP
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics.
    Numans ME; Lau J; de Wit NJ; Bonis PA
    Ann Intern Med; 2004 Apr; 140(7):518-27. PubMed ID: 15068979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy.
    Condra LJ; Morreale AP; Stolley SN; Marcus D
    Am J Manag Care; 1999 May; 5(5):631-8. PubMed ID: 10537869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of 24-h esophageal pH monitoring on the diagnosis of gastroesophageal reflux disease: defining the gold standard.
    Madan K; Ahuja V; Gupta SD; Bal C; Kapoor A; Sharma MP
    J Gastroenterol Hepatol; 2005 Jan; 20(1):30-7. PubMed ID: 15610443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroesophageal reflux disease in bronchial asthma and the response to omeprazole.
    Gopal B; Singhal P; Gaur SN
    Asian Pac J Allergy Immunol; 2005 Mar; 23(1):29-34. PubMed ID: 15997872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empirical trials in treatment of gastroesophageal reflux disease.
    Fass R
    Dig Dis; 2000; 18(1):20-6. PubMed ID: 10729734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?
    Tefera L; Fein M; Ritter MP; Bremner CG; Crookes PF; Peters JH; Hagen JA; DeMeester TR
    Am Surg; 1997 Oct; 63(10):933-6. PubMed ID: 9322676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.